MediWound (NASDAQ:MDWD) Upgraded by StockNews.com to Sell Rating
MediWound (NASDAQ:MDWD – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a report issued on Friday. Other research analysts have also issued reports about the company. HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of MediWound in a research report on Thursday. Craig […]
